Difference between revisions of "Part:BBa K4409010"
LucyShi 2018 (Talk | contribs) |
LucyShi 2018 (Talk | contribs) |
||
Line 3: | Line 3: | ||
<partinfo>BBa_K4409010 short</partinfo> | <partinfo>BBa_K4409010 short</partinfo> | ||
− | This is an RNA-interacting guide RNA (igRNA). It is used in a CRISPR-Cas12 system. It mainly comprises the following three | + | This is an RNA-interacting guide RNA (igRNA). It is used in a CRISPR-Cas12 system. It mainly comprises the following three components. The first component (BBa_K4409000) is the Cas12 handle which combines with Cas12 protein. The second component (BBA_K4409017) is a guide sequence targeting a DNA sequence of GAPDH. The last component (BBa_K4409004) is a control sequence made up of VR1, loop and VR2 regions in sequence. VR1 and VR2 regions can specifically bind to the RNA trigger which is a unique sequence of hsa_circ_0001982. The loop binds to the guide (BBA_K4409017). |
− | When hsa_circ_0001982 is present in the CRISPR-Cas12 system, the control sequence binds with it and the igRNA is activated. The loop then unblocks the guide. The guide binds to a GAPDH dsDNA with the PAM sequence, and activates the Cas12 protein, resulting in the cleavage of dsDNA and ssDNA in the system. | + | When hsa_circ_0001982 is present in the CRISPR-Cas12 system, the control sequence (BBa_K4409004) binds with it and the igRNA is activated. The loop then unblocks the guide(BBA_K4409017). The guide binds to a GAPDH dsDNA (BBa_K4409006) with the PAM sequence, and activates the Cas12 protein, resulting in the cleavage of dsDNA and ssDNA in the system. |
[[File:Hz1-part-1-3.png|500px|thumb|center|Graph 1 Figure Schematic representation of the inactive (A) and active(B,C) igRNA in a CRISPR-Cas12 system.]] | [[File:Hz1-part-1-3.png|500px|thumb|center|Graph 1 Figure Schematic representation of the inactive (A) and active(B,C) igRNA in a CRISPR-Cas12 system.]] |
Latest revision as of 06:22, 11 October 2022
igRNA (CT+GAPDH as guide+ hsa_circ_0001982 as trigger)
This is an RNA-interacting guide RNA (igRNA). It is used in a CRISPR-Cas12 system. It mainly comprises the following three components. The first component (BBa_K4409000) is the Cas12 handle which combines with Cas12 protein. The second component (BBA_K4409017) is a guide sequence targeting a DNA sequence of GAPDH. The last component (BBa_K4409004) is a control sequence made up of VR1, loop and VR2 regions in sequence. VR1 and VR2 regions can specifically bind to the RNA trigger which is a unique sequence of hsa_circ_0001982. The loop binds to the guide (BBA_K4409017). When hsa_circ_0001982 is present in the CRISPR-Cas12 system, the control sequence (BBa_K4409004) binds with it and the igRNA is activated. The loop then unblocks the guide(BBA_K4409017). The guide binds to a GAPDH dsDNA (BBa_K4409006) with the PAM sequence, and activates the Cas12 protein, resulting in the cleavage of dsDNA and ssDNA in the system.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Usage and Results
In order to test the efficiency of this sequence, we put this sequence into the Cas12a system we constructed. Coupled with Cas12a enzyme, probe, buffer, and dsDNA, fluorescence is being produced. We use ImageJ to measure the fluorescence level in each tests tube. From left to right, each test tube contains different concentration of circRNA from different sources, marked as following: Cell extract from cancer cell 1μl, cell extract from cancer cell 0.5μl, cell extract from cancer cell 0.25μl, cell extract from cancer cell 0.125μl, cell supernatant from cancer cell 1, cell supernatant from cancer cell 2, positive control group, negative control group. Concentration of all other substance is controlled the same.
The fluorescence produced is recorded in the following table. The value of d% is calculated as the following formula
Conclusion
Since when circRNA is present, the fluorescence produced is significantly higher than the negative control groups when circRNA is not present. This proves that igRNA we design is a workable one since only when circRNA is present, fluorescence can be produced. This serves as a switch for the whole system.